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ABSTRACT 
Patient, Disease and Surgical Parameters 
in the Prediction of Histologic Nodes and Recurrence of 
Squamous Cell Carcinoma 
by 
Adolfo A. Ferreira 
This research explores the impact of a variety patient, disease and lesion 
parameters upon the probability of post surgery recurrence of squamous cell 
carcinoma and the involvement of histologic nodes. 	 It was found that 
parameters such as number of nodes, Lymph Vascular Space Invasion (LVS), 
figo stage, growth rate and host response as well as tumor thickness, depth of 
invasion and lesion size are good predictors. Other parameters such as cell type 
and condylomas were found to correlate minimally with recurrence and 
histologic nodes. Surgical parameters such as surgical margin and distance 
surgical margin were found to have poor correlation with either recurrence or 
histologic node involvement. 
In addition, a statistical model was developed to predict the likelihood of 
disease recurrence and histological node involvement based on the parameters 
found significant in this study. 
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CHAPTER 1 
INTRODUCTION 
Squamous cell Carcinoma is a tumor or cancer of the skin. Squamous cells are 
the flat, scalelike epithelial cells that act as coverage to the body and line the 
walls of the hollow structures within the body, resting above a homogeneous 
noncellular basement membrane. The tumor is the result of the keratinization 
or hardening of the epidermal cells. Keratins are a fibrous protein that forms 
horny tissues, such as fingernails, and that can also be found in the skin and 
hair. Keratins are a type of the intermediate filament proteins of 70 to 100 A 
in diameter that contribute to the mechanical stability of the sheets of epithelial 
cells. Thus, keratinization may be defined as the development of a horny 
growth or nodule in the epidermal tissue. The growth of the horny nodule is 
usually slow. However, if left untreated it can ulcerate and invade underlying 
tissues. Metastasis to the regional lymph nodes can also occur. 
Exposure to the sun's ultraviolet rays, presence of premalignant lesions 
such as actinic keratosis, chronic skin irritation, exposure to carcinogens and 
some hereditary diseases are believed to be involved with development of 
squamous cell carcinoma. A carcinoma is any cancer that arises in the 
epithelium and probably metastasize via the lymphatic system. Carcinomas 
1 
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develop mostly on the sun exposed areas of the body such as face, ears, neck 
and back of the hands. However, they can be found in other areas of the body. 
In women, they are often found in the vulva. 
Surgery is often the recourse for treatment of squamous cell carcinoma. 
When recommending surgery, the physician needs to evaluate the likelihood of 
success: elimination of the carcinoma with no tumor recurrence. 	 By 
understanding the influence of key parameters that may help predict the 
outcome of the surgery a better decision for the course of treatment can be 
made. In a study involving patients who had histologic positive nodes on the 
neck, 21 % had recurrence after surgery'. The same study also indicated that 
recurrence after a standard dissection was almost invariably fatal. Thus 
minimizing the likelihood of recurrence is critical for the success of the surgery. 
The influence of various patient, disease and surgical parameters on the 
likelihood of recurrence or the metastasis of the nodes involvement is the 
subject of this study. 
1
 Gordon B Snow et al, Prognostic Factors in Neck Metastasis; Larson, D.; 
(eds) Cancer in the Neck; Macmillan; NY; 1986 
CHAPTER 2 
BACKGROUND ON SQUAMOUS CELL CARCINOMA 
2.1 What is Squamous Cell Carcinoma? 
Squamous cell carcinoma is a cancer of the epithelial tissues. It results in the 
formation of a hardened, horny "mole" in the epithelial tissues above the 
basement membrane. If not treated, these moles may ulcerate and metastasize 
to other parts of the body. 
Tumors may be classified as either malignant or benign. Malignant 
means that the cancer is capable of spreading onto other areas of the body 
(metastasize). A benign growth will be localized to the tissue from which it 
generated. Indicators for the transformation from an harmless mole to a 
cancerous tumor include changes in the shape or size of the mole. The rate of 
change in itself is also an indicator. If the rate is slow, it is unlikely that the 
tumor is malignant. Changes involving malignant growths are fast and may 
occur within a period of months. Thus, one should always pay attention to 
changing moles. 
3 
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2.2 Metastases of the Tumors 
The danger of any cancer resides principally on it's capability to spread or 
metastasize. Metastasis is the spread of malignant tumors away from their site 
of origin. For some reason, the tumor does not trigger an effective rejection 
response by the host. Otherwise, the early mass of the tumor would be 
destroyed. The exact reasons for the body not to initiate an effective response 
are unknown. 
The main routes for the spread of the tumor are (I) through the blood 
stream, (2) through the lymphatic system and (3) across body cavities. Tumors 
may spread through one or more of these routes. 	 Subcutaneous and 
intracutaneous metastases may either be transported by the blood or the lymph. 
If the new deposit is far away from the original tumor and not related to the 
draining lymph vessels, it is probably blood transported. If the metastasis is in 
an area anatomically related to the primary tumor it usually is in a line from the 
primary tumor to the draining lymph nodes. If the route of spreading is the 
lymphatic system, chances are that a secondary tumor will be found in the 
lymph nodes. The lymph nodes act as filters or barriers to the spread of the 
cancer and may and contain a large concentration of malignant cells. 
Eventually the barrier may be overcome and the cancer may spread to other 
parts of the body. Squamous cell carcinoma is believed to spread mainly 
through the lymphatic system. 
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3.3 Treatments of Squamous Cell Carcinoma 
The best treatment for squamous cell carcinoma, or for any other cancer, starts 
with early detection. Treatment success usually depends on the anatomical 
localization of the tumor and degree of metastasis. The general population, as 
well as family physicians, should be aware that a new or a changing mole may 
possibly be malignant. As with most cancers, early detection and treatment 
increases the probability of cure and long therm survival. Common treatments 
for squamous cell carcinoma may be divided onto non-surgical and surgical or 
both. The choice of treatment depends on various factors including the location 
of the primary tumor, status of the lymph nodes and level of metastasis. 
Some of the conventional non-surgical treatments that may be used 
include: 
Immunotherapy: 
Some approaches have involved using antigens isolated from cell 
membranes. To date these treatments have been largely unsuccessful. 
Hope resides in the biotechnology field for more effective ways of 
bolstering the immune system to respond to the spreading of the 
carcinoma. 
6 
Chemotherapy: 
Some success has been achieved on shrinking and partially destroying 
the carcinoma by cancer chemotherapy (1) using a wide range of drugs. 
A combination of chemotherapy and immunotherapy may offer some 
hope. However, the successes of chemotherapy can be considered meager 
on complete eradication of squamous cell carcinoma. 
Radiotherapy: 
Radiotherapy has been widely used both by itself and in conjunction with 
surgery. Radiotherapy has been shown to be most efficient in the early 
stages of squamous cell carcinoma. Radiotherapy has been also used 
with patients that had tumor recurrence after surgery and in conjunction 
with surgery to attempt to minimize the risk of recurrence. 
All the above therapies have had limited success. Thus, surgical removal 
of the tumor is the most likely to succeed in eliminating the carcinoma. The 
surgeons involved with surgical removal of malignant carcinomas are a special 
breed. They must be familiar with a large number of anatomical areas, make 
decisions about the metastic potential of the carcinoma and decide the extent 
of the surgery. Finally, the surgeon must be familiar with reconstruction 
techniques in order to maximize function restoration while minimizing the 
cosmetic impact. 
After deciding to proceed with the surgery, decisions have to be made 
as to how widely and deeply to excise the cancer, future follow up procedures 
and possibility of recurrence. The next chapters deal with estimating the 
likelihood of success given a series of surgical, anatomical and patient 
attributes. 
CHAPTER 3 
PARAMETER SIGNIFICANCE 
A total of 117 patients were involved on this study. Due to missing data or 
other problems, the total number of patients used for the statistical evaluation 
was reduced to 93. From these, three groups were formed based on the medical 
treatment history of the patients. Groups 1 included patients which had 
recurrence, group 2 included patients with node involvement and group 3 
included patients with both recurrence and node involvement. Patients in group 
one or three were used to estimate recurrence while patients in group two or 
three were use for estimation of the involvement of histologic nodes. For each 
patient, a series of patient attributes and surgical parameters were determined 
and the various levels within each parameter tabulated. Appendix two details 
parameter information. Statistical significance of the levels of the various 
parameters was assessed level by means of a one-way analysis of variance, least 
significant difference method. 
The analysis of variance is based on the assumption that the basic density 
function of the data is normal and that errors are normally and independently 
distributed with mean zero and variance a'. However, even in instances were 
data depart from normality, the analysis of variance can provide a good 
indication of significance. 
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The basic mathematics of the analysis of variance are based on a measure 
of the total variability of the data as a sum of its terms and also that a specific 
source of variation can be attributed to each term. With reference to this 
analysis, the two main sources of variation may be due to (1) actual differences 
in the probability for recurrence or histologic node involvement and (2) 
experimental error. If x, bar denotes the mean of the ith sample and 	 denotes 
the jth observation of the ith sample and SST is the total sum of squares, then the 
following equation is the basis for the analysis of variance. Where the first 
term represents the variation among the sample (levels) means while the second 
term represents variation within the individual samples or levels. They are 
commonly known as the treatment sum of squares SS(Tr) and the error sum of 
squares (SSE) respectively. The second term is also known as experimental 
error. 
To assess statistical significance, the analysis of variance uses the F test 
to determine that the null hypothesis that the samples with means µ I , 
are all from the same population. The F ratio can also be called the variance 
ratio and in the case of the analysis of variance it can be simply expressed as 
Estimate of σ2 based on the variation among the X 
F= bars 
Estimate of o2 based on the variation among the 
samples. 
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When the null hypothesis holds (samples are from the same population), the 
ratio should be approximately one and the ratio increases (significance level 
goes down) as the populations differ. 
The analysis of variance is usually reserved for experiments involving 
more than two samples. However, for simplicity, the analysis of variance was 
also used for parameters with only two classes. As demonstrated by Snedecor, 
the F test can be shown equivalent to the t test which is usually used to 
compare the means of two independent samples. By applying the same test to 
each parameter, significance was easily ranked. 
A cursory inspection of the data clearly shows that it does not follow a 
normal density function, a basic assumption of the analysis of variance. To 
confirm the results of the analysis of variance a Kruskal-Wallis rank sums test 
was also performed on the non-parametric data. Kruskal-Wallis provides a non-
parametric alternative for the one-way analysis of variance. These methods are 
also called distribution free methods since they do not require normality or even 
knowledge of data distribution. For the test, the data are ranked (rank 
transformation) and a Chi square is performed on the sum of the ranks assigned 
to the observations in the samples. That is, the Kruskal-Wallis method tests the 
null. hypothesis that the treatments are the same against the alternative 
hypothesis that some of the treatments generate larger observations. The test 
is based on the statistic 
11 
Figure 1 Typical plot of residuals by class 
If the null hypothesis holds true then the sampling distribution can be 
approximated with a chi-square distribution with k - 1 degrees of freedom. 
Whenever the analysis of variance and the Kruskal-Wallis test yield 
similar results, the analysis of variance assumptions are reasonably satisfied and 
the results should hold. In addition to the comparison with non-parametric 
methods, an analysis of the residuals was also performed on the analysis of 
12 
variance. The residuals can provide some indication of patterns on the data. 
Typical residual plots are shown in Figures 1 and 2. 
Figure 2 Typical residuals by index 
Table 1 shows the decreasing order of significance for predicting the 
recurrence of squamous cell carcinoma. Both the results of the analysis of 
variance and the Kruskal-Wallis test are presented. Very good correlation 
between the two methods is demonstrated. It should be noted that the lower the 
significance the higher the probability that the factor levels have a relationship 
with the outcome (such as recurrence). 
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TABLE 1 Significance of Parameters on Recurrence (Groups 1 or 3, by 
decreasing significance) 
Parameter ANOVA Kruskal- 
Wallis 
Figo stage 0.000 0.000 
LVS 0.009 0.009 
Host Response 0.012 0.014 
Lesion Site 0.013 0.015 
Histologic nodes 0.030 0.031 
Mitosis 0.076 0.077 
Number of Nodes 0.128 0.134 
Growth 0.139 0.138 
Dysplasia 0.175 0.174 
CIS 0.206 0.204 
Group 0.209 0.207 
Grade 0.348 0.344 
Surgical Margin 0.502 0.492 
Keratin 0.576 0.570 
Distance Surgical Margin 0.788 0.783 
Cell Type 0.823 0.819 
Dystrophy 0.843 0.839 
Condylomas 0.976 0.976 
Figo stage, lymph vascular space invasion (LVS), host response, lesion 
site histologic nodes were found to be the best predictors of recurrence while 
condylomas, dystrophy and cell type were found to have minimal correlation. 
Gordon (7) found that the most important factor regarding recurrence of 
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squamous cancer was histologic nodal involvement followed by the number of 
nodes involved. While this is in general agreement with our findings, Meyers 
found no significance regarding the number of nodes involved and the 
probability of recurrence. Table 2 shows the significance of the same 
parameters for the presence of histologic nodes. Parameters such as LVS, figo 
stage, growth and group were found to be good predictors. 
TABLE 2 Significance of Parameters on Histologic nodes 
(Groups 2 or 3, by decreasing significance) 
Parameter ANOVA Kruskal- 
Wallis 
Figo stage 0.000 0.000 
LVS 0.000 0.000 
Growth 0.000 0.001 
Group 0.003 0.003 
Host Response 0.017 0.019 
Dystrophy 0.158 0.157 
Lesion Site 0.233 0.231 
CIS 0.261 0.258 
Keratin 0.273 0.269 
Distance Surgical Margin 0.500 0.494 
Mitosis 0.532 0.526 
Surgical Margin 0.661 0.653 
Dysplasia 0.688 0.681 
Grade 0.875 0.872 
Condyloma 0.877 0.873 
Cell Type 0.931 0.929 
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It should be noted that number of nodes, LVS, figo stage, growth and 
host response are good predictors for both histologic nodes and recurrence. 
There are some parameters, that although not statistically significant, 
warrant further investigation. In some cases, the number of patients within a 
certain level of a particular parameter was small as compared to the other 
level(s). A typical example is surgical margin and histologic node involvement, 
with input values of 0 (some surgical margin) and 1 (no surgical margin) having 
a frequency of 75 and 4 respectively. Thus, the confidence interval for a 
response of 1 is very large and the estimated probabilities are difficult to 
pinpoint. However, a closer look (see Tables 3 and 4) at the expected values 
for the group shows a 30% difference in probabilities for histologic nodes and 
a 78% difference for recurrence. 
Other parameters exhibited similar patterns. Tables 3 and 4 show the 
parameters with similar occurrences. It is possible that significant correlations 
would emerge if a larger data base of patients with diverse responses were 
available. It is worth noting that surgical margin is present in both tables. Thus, 
it appears to be an important factor for estimation of the likelihood of 
recurrence and/or histologic nodes. 
 To increase the data base for estimating recurrence, all groups were 
combined and significance reassessed. Table 5 shows the level of significance 
for the various parameters for all groups along the results for groups 1 or 3. 
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TABLE 3 Parameters Found Non-Significant With Large Differences in 
Probabilities For Histologic Nodes 
Parameter Group Count P 
Surgical Margin 
0 75 0.38 
1 4 0.50 
Dist. Margin 
0 51 0.35 
1 11 0.55 
2 17 0.41 
TABLE 4 Parameters Found Non-Significant With Large Differences in 
Probabilities For Recurrence 
Parameter Group Count P 
Surgical Margin 
0 83 0.28 
1 2 0.50 
Grade 
0 14 0.14 
1 44 0.34 
2 27 0.25 
Growth 
0 28 0.14 
1 23 0.35 
2 34 0.34 
Dysplasia 
0 28 0.32 
1 19 0.16 
 The increased data base showed significance for surgical margin and 
Dysplasia. 	 Significance for growth may be considered marginal while 
significance for grade was not demonstrated. 
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TABLE 5 Significance of Parameters on Recurrence 
Parameter Groups 1 or 3 All Data 
Figo stage 0.000 0.000 
LVS 0.009 0.001 
Host Response 0.012 0.013 
Lesion Site 0.013 0.002 
Histologic nodes 0.030 0.015 
Mitosis 0.076 0.215 
Number of Nodes 0.128 0.176 
Growth 0.139 0.221 
Dysplasia 0.175 0.058 
CIS 0.206 0.141 
Group 0.209 0.064 
Grade 0.348 0.445 
Surgical Margin 0.502 0.054 
Keratin 0.576 0.651 
Distance Surgical Margin 0.788 0.948 
Cell Type 0.823 0.728 
Dystrophy 0.843 0.393 
Condylomas 0.976 0.560 
Parametric parameters, such as lesion size, depth of invasion and tumor 
thickness were also tabulated. Due to the large range in values, class sizes were 
deemed too small for an analysis of variance. To assess the influence of these 
parameters a regression analysis was performed. 
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Figure 3 Regression of lesion size on histologic nodes (Steeper slop had one 
outlier removed) 
The correlation coefficients were calculated after placing the data into 
tabular form with a class size of 2 mm. For tumor thickness and depth of 
invasion all data above 12 mm were classified into one class. The average 
thickness for each interval was calculated as well as the corresponding expected 
probability of recurrence or histologic nodes. The results for each parameter 
were then regressed with either recurrence or histologic nodes. Again, groups 
one and three were regressed with the probability of Recurrence while groups 
two and three were regressed with histologic nodes. A typical result is shown 
I9 
Figure 4 Regression of lesion depth on histologic nodes 
in Figure 3. The graph shows the regression line using all groups along with a 
regression line where an outlier subgroup has been removed from the analysis. 
The other groups had no evidence of outliers. A typical example is shown in 
figure 4. 
Due to the separation of the data onto classes of equal increments, the 
outlier had only four data points. Consequently, the confidence interval for 
probability estimation was very large. Table 6 shows the correlation 
coefficients and slopes for depth of invasion, tumor thickness and lesion site for 
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recurrence and histologic nodes. The correlation coefficients are relatively high 
for this data, and the slopes are significantly different from zero, indicating a 
strong relationship between these parameters and the probability of recurrence 
and histologic nodes. 
TABLE 6 Correlation Coefficients for Parametric Data 
Parameter 
Recurrence Histologic Nodes 
Corr. Coef. Slope Corr. Coef. Slope 
Tumor Thick. (mm) 0.85 0.030 0.94 0.046 
Depth of inv. (mm) 0.86 0.050 0.90 0.051 
Lesion Size (mm) 0.86 0.052 
0.52* 0.030 
0.99 0.088 
* With outlier subgroup 
In conclusion, some patient attributes and surgical parameters were 
found to be strong indicators in assessing the likelihood of recurrence of 
squamous cell carcinoma and on the involvement of histologic nodes. In 
particular, parameters such as number of nodes, LVS, figo stage, growth, host 
response, tumor thickness, lesion site and size and depth of invasion were found 
to correlate well with both recurrence and histologic node involvement. 
CHAPTER IV 
ESTIMATION OF PROBABILITY RANGES 
The probability of recurrence and the involvement of histologic nodes for 
each class within a given parameter was estimated. The probability p of 
recurrence or involvement of histologic nodes was estimated by dividing the 
number of occurrences by the number of patients. The 95% confidence interval 
for p was also estimated. To calculate the interval, an approximation to the 
normal distribution was used. The standard deviation of the mean of a binomial 
distribution is given by 
Where p is the probability of recurrence and g is the probability of non-
recurrence or 1-p. 
Thus, the 95% confidence interval (estimated range for the probability) for p is 
approximated by p ± 2a. 
The range in overall probabilities for recurrence and histologic node 
involvement are given in Table 7. 
21 
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TABLE 7 Overall Probabilities 
Group (n) 
p 95% interval 
Recurrenc 
e 
Hist. nodes Recurrence Hist. nodes 
All (93) 0.31 0.76 0.21 	 - 0.41 0.67 - 0.85 
1 & 3 (85) 0.28 0.75 0.18 - 0.38 0.65 - 0.85 
2 & 3 (79) 0.39 0.29 - 0.49 
Tables 8 through 10 show the confidence intervals for the various 
parameters. Whenever the low limit of the interval fell below zero, it was 
rounded to zero. The upper limit was rounded to one. 
It can be seen that, in many cases, the ranges of probability of recurrence 
or histologic node involvement are quite large and some levels overlap. While 
this indicates that the parameter levels may not be a significant factor, it can 
provide a basis for further study. For example, increasing the number of 
patients will reduce the size of the range and provide for better estimates. 
23 
TABLE 8 Confidence Intervals for p of Recurrence (Groups 1 or 3) 
Parameter 
Class 
0 1 2 3 4 
Figo stage 0.00 - 0.16 0.11 - 0.42 0.35 - 0.81 1.00 
LVS 0.10 - 0.30 0.26 - 0.68 
Host response 0.00 - 0.26 0.04 - 0.30 0.28 - 0.60 
Lesion site 0.00 - 0.33 0.00 - 0.15 0.19 - 0.55 0.24 - 0.66 
Hist. nodes 0.09 - 0.33 0.28 - 0.68 0.00 - 0.35 
Mitosis 0.16 - 0.62 0.20 - 0.62 0.07 - 0.29 
# of nodes 0.09 - 0.33 0.01 - 0.59 0.19 - 1.00 0.00 - 1.00 
Growth 0.01 - 0.27 0.15 - 0.55 0.19 - 0.51 
Dysplasia 0.21 - 0.43 0.00 - 0.33 
CIS 0.20 - 0.46 0.07 - 0.35 
Group 0.00 - 0.33 0.20 - 0.42 
Grade 0.00 - 0.33 0.20 - 0.48 0.09 - 0.43 
Surgical 
margin 
0.18 - 0.38 0.00 - 1.00 
Keratin 0.08 - 0.54 0.17 - 0.49 0.08 - 0.36 
Dist. Margin 0.18 - 0.42 0.05 - 0.45  0.06 - 0.46 
Cell type 0.18 - 0.40 0.05 - 0.45 0.21 - 0.87 
Dystrophy 0.15 - 0.43 0.14 - 0.40 
Condylomas 
* For number of nodes, classes above classification 3 were combine onto one class 
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TABLE 9 Confidence Intervals for p of Histologic Nodes (Groups 2 or 3) 
Parameter 
Class 
 
0 1 2 3 
Figo stage 0.01 - 0.31 0.14 - 0.48 0.51- 0.89 1.00 
LVS 0.12 - 0.36 0.57 - 0.93 
Growth 0.01 - 0.29 0.51 - 0.89 0.19 - 0.55 
Group 0.61 1.00 0.23 - 0.45 
Host Resp. 0.00 - 0.45 0.09 - 0.41 0.39 - 0.71 
Dystrophy 0.31 - 0.61 0.17 - 0.47 
Lesion site 0.00 - 0.54 0.03 - 0.47 0.19 - 0.57 0.34 - 0.74 0.0 - 1.0 
CIS 0.30 - 0.58 0.14 - 0.48 
Keratin 0.18 - 0.74 0.29 - 0.67 0.15 - 0.45 
Dist. margin 0.22 - 0.48 0.25 - 0.85 0.17 - 0.65 
Mitosis 0.10 - 0.62 0.10 - 0.50 0.29 - 0.59 
Surgical 
margin 
0.28 - 0.50 0.00 - 	 1.00 
Dysplasia 0.26 - 0.50 0.19 - 0.69 
Grade 
Condylomas 0.28 - 0.52 0.14 - 0.62 
Cell type 0.28 - 0.52 0.00 - 0.71 0.00 - 0.87 
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TABLE 10 Confidence Intervals for p of Recurrence (All data) 
Parameter 
Class 
0 1 2 3 4 
Figo stage 0.00 - 0.16 0.16 - 0.46 0.36 - 0.76 1.00 
LVS 0.10 - 0.30 0.37 - 0.73 
Host resp. 
Lesion site 0.00 - 0.33 0.00 - 0.15 0.19 - 0.55 0.33 - 0.71 
Hist. nodes 0.11 - 0.35 0.32 - 0.68 0.00 - 0.35 
Mitosis 0.16 - 0.62 0.22 - 0.62 0.12 - 0.40 
# of nodes 0.12 - 0.36 0.00 - 0.54 0.20 - 0.94 0.09 - 0.91 
Growth 0.05 - 0.33 0.20 - 0.58 0.20 - 0.52 
Dysplasia 0.25 - 0.47 0.00 - 0.29 
CIS 0.24 - 0.50 0.08 - 0.36 
Group 0.00 - 0.33 0.29  - 0.97 0.20 - 0.42 
Grade 
Surgical 
margin 
0.19 - 0.39 0.32 - 1.00 
Keratin 0.16 - 0.62 0.16 - 0.48 0.12 - 0.40 
Dist. Margin 0.18 - 0.42 0.06 - 0.60 0.12 - 0.54 
Cell type 0.22 - 0.44 0.00 - 0.45 0.21 - 0.87 
Dystrophy 0.22 - 0.50 0.14 - 0.40 
Condylomas 0.20 - 0.40 0.14 - 0.62 
* For number of nodes, classes above classification 3 were combine onto one class 
CHAPTER V 
PREDICTION MODEL 
The previous chapters evaluated the relationship of various surgical parameters 
and patient attributes with squamous cell carcinoma recurrence and histologic 
node involvement. In this chapter, it is attempted to develop a statistical model 
that can reasonable predict the probability of recurrence or the involvement of 
histologic nodes. The model uses only the parameters found significant by the 
analysis of variance methodology. The model is based on the sigmoidal 
function of the form: 
where A, B, and a are patient and disease parameters while M determines the 
inflection points. 
The output of the sigmoidal function follows an S type curve, as shown 
in figure 5, approaching a minimum and a maximum value asymptotically. 
The type of data involved in this study should fit the sigmoidal function. For 
example, the probability of carcinoma recurrence after surgery should be 
expected to start at some value above 0 and increase to a maximum of 1. The 
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Figure 5 Typical sigmoidal function. 
approach to the maximum and minimum should be smooth and is best 
represented by an asymptotic curve. 
In the model presented here, multiple independent variables or parameters 
are combined onto a single equation of the form outlined by equation 4. For 
each of the output variables - recurrence or histologic node involvement - one 
equation was developed for non-parametric and another for parametric data. 
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The overall model development consists of a series of steps. 
Development of the equation for predicting recurrence based on non-parametric 
inputs is detailed here. Similar steps were used to develop the equations for the 
parametric data and for estimation of histologic node involvement and are 
shown in the Appendix. 
For each input variable found significant by a one way analysis of 
variance, the probability of recurrence was simply calculated by dividing the 
patients with recurrence by the number of patients involved. The data for each 
input variable was fitted onto the model y = AeBx, where y is the probability of 
recurrence. Transformation of this equation yields 
and further 
the familiar linear model. Thus, the Ln of the probability p of recurrence at a 
given level was regressed, by means of a least squares linear regression, with 
that variable level. Table 11 lists the results of the regressions for the 
significant parameters. 
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TABLE 11 Logistic Regression for Parameters Influencing Recurrence 
Parameter Intercept 
(CO 
Slope 
(C1 ) 
Correlation 
(R) 
C1*R 
Figo stage -3.2 0.83 0.98 0.81 
LVS -1.6 0.85 1 0.85 
Host Resp. -2.2 0.61 0.95 0.58 
Rec. Site -2.3 0.47 0.72 0.34 
# of Nodes -1.5 0.33 0.89 0.29 
Growth -1.8 0.45 0.87 0.39 
Surgical 
Margin 
-1.3 0.58 1 0.58 
Mitosis -0.8 -0.39 0.44 - 
Hist. Nodes -1.3 -0.08 0.14 - 
The above parameters were then combined onto a single equation of the form 
where A is the maximum probability of recurrence and therefore must be equal 
to one. B can be calculated if the intercept of the Y axis as the independent 
variable equals zero is known. The Y intercept can be estimated by calculating 
the average intercept Co. For N variables the intercept may be approximated 
by 
In our case P(Rx=0) = 0.14. Thus, under normal circumstances a patient with 
minimal involvement with the above parameters may have a 14% chance that 
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recurrence will occur. B is then easily calculated by plugging in the values 
with αM = 0, A = 1 and P(Rx=0) = 0.14. 
The values for aM are calculated from the values for the slope and correlation 
coefficient. Parameters with low correlation, such as mitosis and histologic 
node involvement were not used for the development of the general equation. 
The slopes for each parameter were weighted by multiplying with the 
correlation coefficient. Thus, parameters with lower correlations will have less 
of an influence on the general equation. Further, the correlation coefficient is 
somewhat related to the inflexion points of the general curve. In addition, since 
multiple parameters are used on the general equation, the transformation must 
account for the number of parameters. To that end, aM can be calculated as 
follows 
Substitution yields, for recurrence, aM = 0.21 Figo + 0.22 LVS + 0.15 Host 
Resp. + 0.09 Rec. Site + 0.08 # Nodes + 0.1 Growth + 0.15 Sur. Margin. 
Overall, the results agree with the empirical data. 
A similar approach was used for developing the general equations for the 
probability of recurrence using the parametric parameters as well as for the 
general equations for histologic involvement. These equations can be found in 
the Appendix. 
CHAPTER V 
CONCLUSION 
In conclusion, patient parameters such as number of nodes, LVS, figo stage,host 
response, tumor thickness, depth and size were found to be good predictors of 
recurrence and/or histologic node involvement. Surgical parameters such as 
Surgical margin and distance surgical margin were found to have minimum 
impact. 
Further, a statistical model was developed that may be used to estimate 
the probability of recurrence based the attributes found significant in the course 
of this research. The model should be particularly useful for aiding the surgeon 
determining potential parallel treatments to surgery. 
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Intercept Slope Correlation 
-2.2 0.19 0.82 
-2.1 0.15 0.87 
-2.0 0.10 0.79 
-6.3 0.44 
-2.1 
Recurrence using parametric data - Groups 1 & 3 
Parameter 
Size 
Depth 
Thick 
Ʃ/n 
APPENDIX ONE 
Calculations for the general equations 
Estimate of intercept = e-2.1 = 0.12 
From P(C=0) = 0.12 then B = 7.3 
and aM = 0.35 Size + 0.30 Depth + 0.18 Thickness 
Histologic node involvement using non-parametric data: Groups 2 & 3 
Parameter Intercept Slope Correlation 
Figo stage -2.4 0.63 0.99 
LVS -1.4 1.14 1 
Growth -1.5 0.45 0.58 
Host -2.1 2.68 1 
Response 
Ʃ  
-7.4 4.9 
Ʃ/n 
-1.9 
Estimate of intercept = e-1.85 = 0.16 
From P(C=0) = 0.16 then B = 5.3 
and aM = 0.13 Figo + 0.23 LVS + 0.07 Growth + 0.67 Host 
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Histologic node involvement using parametric data: Groups 2 & 3 
Parameter Intercept Slope Correlation 
Size -1.3 0.08 0.72 
Depth -1.9 0.13 0.84 
Thick -3.1 0.23 0.60 
E 
Ʃ /n 
-6.3 
-2.1 
0.44 
Estimate of intercept = e-2.1 = 0.12 
From P(C=0) = 0.12 then B=7.3 
and αM = 0.13 Size + 0.25 Depth + 0.31 Thick 
1 
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PROBABILITIES OF RECURRENCE 
Based on the Proposed Model 
Non - Parametric Parametric 
Parameter Parameter 
Level 
P Parameter Parameter 
level 
P 
Figo 0 Size 0 
0. 14 
 
LVS 0 Depth 0 
Host 0 Thickness 0
Site 0 Size 1 
0.23 
 
#Nodes 0 Depth 1 
Growth 0 0.14 Thickness 1 
Margin 1 Size 2 
0.34 
Figo 1 
0.31 
Depth 2 
LVS 1 Thickness 2 
Host 1 Size 3 
0.48 
Site 1 Depth 3 
#Nodes 1 Thickness 3 
Growth 1 Size 4 
0.62 
Margin 1 Depth 4 
Figo 2 
0.45 
Thickness 4 
LVS 1 Size 5 
0.75 
Host 2 Depth 5 
Site 2 Thickness 5 
#Nodes 2 Size 6 
0.84 
Growth 2 Depth 6 
Margin 1 Thickness 6 
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PROBABILITIES OF HISTOLOGIC NODE INVOLVEMENT 
Based on the Proposed Model 
Non - Parametric Parametric 
Parameter Parameter 
Level 
P Parameter Parameter 
level 
Figo 0 
0.16 
Size 0 
0.12 LVS 0 Depth 0 
Host 0 Thickness 0 
Growth 0 Size 1 
0.20 Figo 1 
0.36 
Depth 1  
LVS 1 Thickness 1 
Host 1 Size 2 
0.30 Growth 1 Depth 2 
Figo 2 
0.56 
Thickness 2 
LVS 1 Size 3 
0.44 Host 2 Depth 3 
Growth 2 Thickness 3 
Figo 3 
0.61 
Size 4 
0.58 LVS 1 Depth 4 
Host 2 Thickness 4 
Growth 2 Size 5 
0.71 Figo 4 
0.64 
Depth 5 
LVS 1 Thickness 5 
Host 2 Size 6 
0.82 Growth 2 Depth 6 
Thickness 6 
Size 7 
0.89 Depth 7 
Thickness 7 
Size 8 
Depth 8 0.93 
Thickness 
APPENDIX TWO 
PARAMETER LEVEL DEFINITION 
Group 	  1-Recurrence; 2-Node; 3- Both 
Figo (FIGO 1988)  
 1-I; 2-11; 3-111; 4-IVa 
LVS (Lymph Vascular Space Invasion) 
	
 0-Yes; 1-No 
Host Response 	  0-Marked; 1-Moderate; 2-Mild 
Lesion Site 	
 0-Clitoris; 1-Labia minora; 2-Labia majora; 3-All 
Lesion Size 	
 mm 
Histologic Nodes 	  0-Yes; 1-No; 2-lost to follow up 
Mitosis 	
 0-(0-5); 1-(5-10); 2 (>10) 
# Nodes 	  Number of Nodes 
Growth 	
 0-Pushing; 1-Mixed; 3-Infiltrating 
Dysplasia 	  0-Yes; 1-No 
CIS (Carcinoma in Situ) 
	
 0-Yes; 1-No 
Grade (Histologic Grade) . . 1-Well differentiated; 2- Moderately; 3-Poorly 
Surgical Margin 	  0-Yes; 1-No 
Keratin 	  0-(.50%); 1-(25-50%); 241-25%) 
Distance Surgical Margin 	  0-(>5mm); 1-(=/<5mm) 
Cell Type. 0-Large Cell Keratinizing; 1-Large Cell Nonkeratinizing; 3-Small 
Cell 
Dystrophy 	  0-Yes; 1-No 
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APPENDIX THREE 
ORIGINAL DATA 
Pat Grp Sur 
Mar 
DMar Depth 
inv 
Thick Growth LVS Mito Kera Grad Cell Fist 
Rsp 
CIS Dysp Dist Cond 
Histo Nodes 
#No Rcc Rec 
Site 
Les 
Size 
Les 
Site 
Figo 
I 3 0 0 3.3 1.5 0 0 0 I 0 0 0 0 0 I I 0 0 0 I 2 I 
2 3 0 2 2.6 2.8 0 0 2 2 2 0 I I 0 0 0 0 0 0 3 3 2 
3 2 0 I 5.04 8 I 1 I 0 I 0 I 0 0 0 I 0 0 I 8 3 3 
4 I 0 0 9 9 I I 1 0 I 0 0 0 I 0 0 3 0 4 3 2 
5 I 0 0 6 6 2 I I 0 I 0 2 0 0 0 0 3 I 2 6 2 2 
6 2 0 I 9.5 9.5 2 I 2 2 2 0 2 0 0 0 0 I 6 I 2 5 3 3 
7 3 0 0 10 10 I 0 0 2 2 2 1 0 0 0 0 0 0 0 10 0 2 
8 3 0 0 2.7 3 2 0 2 2 I I 0 0 I I I 0 0 0 I 3 I 
9 3 0 0 1.8 2.7 2 I 2 2 2 0 2 0 0 0 0 0 0 0 2 1 3 
10 3 0 2 6 6 I I 2 2 2 0 1 I I 0 0 I 1 0 6.5 2 3 
II 3 0 0 19 13 I 1 0 I I 0 2 0 0 I I I 6 1 2 6 3 2 
12 3 I 2 5.04 12 2 0 I 2 2 0 2 0 0 1 0 0 0 I 3 5 2 2 
ORIGINAL DATA 
(Continued) 
Pat Grp Sur 
Mar 
DMar Depth inv Thick Growth LVS Milo Kera Grad Cell Fist 
Rsp 
CIS Dysp Dist Cond 
Histo Nodes 
#No Rec Rec. 
Site 
Les 
Size 
Les 
Site 
Digo 
13 1 0 0 4 4 2 0 I I I 0 2 0 I I 0 3 0 3 3 2 
14 3 0 0 2.5 4.5 0 0 0 2 0 0 I 0 0 I I 0 0 0 1.5 3 1 
15 3 0 I 3 7 2 0 2 0 I 0 2 0 I 0 0 0 0 0 3 2 2 
16 3 0 0 2 7 0 0 2 2 I 0 I I I I I 0 0 0 2 I I 
17 3 0 0 3.6 6 2 I 2 2 1 0 2 0 0 I 0 0 0 0 5 2 2 
I8 I 0 0 6 10 I I 0 I I 0 I 0 0 I 0 I 5 0 6 2 3 
19 3 0 0 2.4 3 0 0 I 2 2 0 0 I 0 0 0 0 0 0 1.5 I 1 
20 3 0 I 5.04 5 I 0 0 0 0 0 I 0 0 I 0 I I 0 3.5 2 2 
21 I 0 0 3 5 I 0 2 1 0 0 2 0 I I 0 3 0 1.5 0 1 
22 3 0 2 6.5 9.5 2 I 0 2 I 0 2 0 0 0 0 I 2 I I 6 3 
23 3 0 0 10 10 1 0 0 I I 0 2 0 0 0 0 I I 1 I 6 2 3 
24 3 0 2 3.5 3.6 2 0 I 2 2 0 2 0 I 1 I 0 0 0 2 1 1 
25 3 0 0 10 10 0 0 1 2 2 0 2 1 0 0 0 0 0 I I 3.5 3 3 
26 3 0 0 1.8 3 2 0 0 I I 0 2 0 0 I 0 0 0 0 1.5 1 I 
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ORIGINAL DATA 
(Continued) 
Pat Grp Sur 
Mar 
DMar Depth 
inv 
Thick Growth LVS Mito Kcra Grad Cell list 
Rsp 
CIS Dysp Dist Cond 
Histo Nodes 
#No Rec Rec 
Site 
Les 
Size 
Les 
Site 
Figo 
27 3 0 1 4 4.5 2 0 2 I 1 0 I I 0 I 0 0 0 I I 3.5 2 3 
28 I 0 1 3.8 4 2 0 2 0 0 0 I I I I 0 3 0 2.7 1 2 
29 3 0 0 2.1 2.9 2 0 2 2 2 0 2 0 0 0 0 0 0 0 1.3 I I 
30 2 0 0 8 8 0 0 2 2 2 0 2 0 I I 0 I I 0 1.4 I 3 
31 3 0 0 5 5 2 1 1 I I 0 2 0 0 I 0 I 3 I 5 2 2 3 
32 3 0 I 3.6 4 2 0 1 I 1 0 2 0 0 I 0 I I 0 I 0 I 
33 3 0 0 2.5 5 0 0 0 0 0 0 I 0 0 0 0 0 0 I I 9 2 2 
34 3 0 I 8.9 9 1 I 2 I I 0 2 0 0 0 0 1 3 0 5 I 2 
35 3 0 I 5 5 2 I 2 1 I 0 2 0 I 0 I I 1 0 1.5 0 I 
36 3 0 0 5.04 7 2 0 2 I I 0 I 0 0 0 I 0 0 0 I 1 I 
37 3 0 0 2.55 2.6 2 I 2 2 2 0 2 I 0 0 I 0 0 0 3 0 2 
38 3 0 I 10 10 2 I 2 1 I 0 2 I 0 0 0 0 0 0 5 2 3 
39 3 0 0 5.5 5.5 1 0 1 I 1 0 2 0 0 I 0 0 0 0 3 0 2 
40 3 0 0 2.97 3 0 0 2 0 0 0 1 0 0 I 0 
 
0 0 0 1 3 1 
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ORIGINAL DATA 
(Continued) 
Pat Grp Sur 
Mar 
DMar Depth 
inv 
Thick Growth INS Mito Kera Grad Cell list 
Rsp 
CIS Dysp Dist Cond Histo 
Nodes 
#No Rec Rec. 
Site 
Les 
Size 
Les 
Site 
Hp 
4I 3 0 0 6.5 6.5 I I 2 2 2 0 2 0 0 0 I I I 1 I 4 3 3 
42 3 0 2 4.2 4.5 2 0 1 2 1 0 1 0 0 I 0 0 0 I I 2 I 1 
43 3 0 0 7 7 2 1 2 I I 0 2 0 0 0 0 I 2 I 7 6.6 2 2 
44 3 0 0 12 25 I I 2 2 2 I 2 I 0 I 0 1 2 I 4 3.5 0 3 
45 3 0 2 9 9 2 I 2 2 2 0 2 0 0 0 0 I 2 0 2.5 2 3 
46 3 0 0 I 2.7 0 0 1 2 2 I 0 I 0 0 0 0 0 0 2 3 1 
47 2 I 2 10 13 I I 2 2 2 0 2 0 0 I 0 I 0 I 1 4 3 2 
48 3 0 0 1.35 2 0 0 2 2 I 0 2 0 0 1 0 0 0 0 8 3 2 
49 I 0 0 4 4 2 0 0 0 0 0 2 1 0 1 0 3 0 I 0 I 
50 3 0 0 1.8 2.5 0 0 2 2 2 0 I 1 1 0 0 0 0 0 4 2 2 
51 2 0 0 6 16 2 0 I I I 0 I 0 0 I 0 I 2 0 6 3 3 
52 3 0 0 1.95 15 I 0 2 0 0 0 I 0 0 0 0 I I 0 7 2 3 
53 3 0 1 4.8 5 I 0 0 0 I 0 2 1 0 I 0 I I 1 I 3 2 2 
54 3 0 0 2.93 3 
 
2 
 
0 2 
 
I 
 
I 0 0 0 
I 
0 
I 
1 
 
0 0 
1 
0 0 
 
1.5 0 I 
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ORIGINAL DATA 
(Continued) 
Pat Grp Sur 
Mar 
DMar Depth 
inv 
Thick Growth INS Mito Kera Grad Cell Hst 
R sp 
CIS Dysp Dist Cond Histo 
Nodes 
#No Rcc 
Rec Site 
Les 
Size 
Les 
Site 
Figo 
55 3 0 0 2 10 0 0 0 0 0 0 1 0 0 1 0 0 0 0 6 2 2 
56 3 0 0 0.75 2.7 0 1 2 I 1 0 I I 0 I 0 0 0 I I 4 3 2 
57 I 0 0 1.5 2.2 0 0 1 0 0 0 2 I I I 0 3 0 3 I 2 
58 I 0 2 1.05 1.2 0 0 2 2 2 I 2 I 0 0 0 3 0 I 0 1 
59 3 0 0 3 4 2 0 I I I 0 I I 0 I 0 0 0 0 1.5 0 i 
60 3 0 2 2.2 2.5 0 0 2 2 1 0 I I 0 I 0 0 0 0 I 2 I 
61 3 0 0 3.5 4 2 0 2 0 0 0 2 1 0 0 I 0 0 I 1 5 2 2 
62 3 I 2 5.04 14 0 0 2 2 2 1 1 1 0 1 0 0 0 0 4 I 2 
63 3 0 0 1.65 4 0 0 2 2 2 0 2 I 0 I 0 0 0 0 4 I 2 
64 I 0 0 2.4 3 0 0 2 2 2 I 1 1 0 0 0 3 0 0.6 1 1 
65 3 0 0 4.8 5 I 0 0 0 I 0 1 0 0 1 0 0 0 0 2 3 I 
66 3 0 I 13 20 0 0 I 2 I I I 0 0 I 0 0 0 0 I 2 I 
67 3 0 2 7 7 2 0 2 I I 0 0 1 0 0 0 0 0 0 6 2 2 
68 3 0 0 15 15 I I 2 I 1 0 1 0 0 0 0 I 5 I I 4 3 4 41  
ORIGINAL DATA 
(Continued) 
Pat Grp Sur 
Mar 
DMar Depth 
ins. 
Thick Growth INS Mito Kera Grad Cell Hst 
Rsp 
CIS Dysp Dist Cond Histo 
Nodes 
#No Rec Rec 
Site 
Les 
Size 
Les 
Site 
Fico 
69 3 0 0 10 10 1 I I I 2 0 2 0 0 I 0 
I 4 I I 10 3 3 
70 3 0 0 2.25 3 0 0 0 I 1 0 I I 0 0 0 0 
0 0 2.5 I 2 
71 I 0 2 1.5 1.5 0 0 2 I 0 0 I 1 0 I 0 3 
0 10 2 2 
72 3 0 2 4.5 5 2 0 0 2 I 0 2 0 0 I 
0 0 0 I 2 4 2 3 
73 3 0 0 5.04 15 0 0 I 2 2 2 2 0 0 0 0 
0 0 I 4 10 3 2 
74 3 0 2 5 5 0 I 2 2 2 I 2 
I 0 0 0 I 3 0 1 1 I 
75 I 0 2 15 15 2 I 0 I 2 I I 0 0 0 0 3 
I 3 7 2 3 
76 3 0 0 3 3.5 1 0 2 I I 0 I 0 0 I 0 I 
4 0 2 3 I 
77 3 0 0 7 10 1 0 2 2 2 0 I I I I I 0 
0 0 6 2 2 
78 2 0 0 5.04 7 0 0 2 0 0 0 2 0 0 0 0 I 2 
I 6 5 3 2 
79 3 0 0 5.04 3 1 0 1 0 0 0 I I 1 0 I 1 
2 0 8 2 3 
80 3 0 0 9.5 10 1 0 1 I I 0 2 0 0 I 0 
0 0 0 3 3 2 
81 3 0 2 7 7 0 0 2 2 1 0 I 0 0 0 0 0 0 
0 1.5 0 I 
82 2 0 0 5.04 9 I 0 2 2 2 0 2 I I 1 0 I 
6 0 8 3 3 42  
ORIGINAL DATA 
(Continued) 
Pat Grp Sur 
Mar 
DMar Depth 
inv 
Thick Growth INS 
Mito 
Kera Grad Cell 
Hst Rsp 
CIS Dysp Dist Cond Histo 
Nodes 
/No Rec Rcc 
Site Les Size 
I ,es 
Site 
Figo 
83 3 0 0 9 10 2 0 2 I I 0 0 I I I 0 0 0 0 4 2 3 
84 I 0 0 0.35 0.5 0 0 0 2 1 I I 1 0 0 0 3 0 0.5 I I 
85 I 0 2 0.9 2 2 1 2 2 I 0 I 0 0 0 0 3 0 3.3 3 2 
86 3 0 2 3 3.2 0 0 2 I I 0 I 0 0 I 0 0 0 0 I 0 I 
87 3 0 2 1.2 3.3 2 0 2 I 2 2 0 0 0 0 0 I I 0 6 2 2 
88 3 0 0 0.6 0.7 0 0 I 2 2 0 I I I 0 0 0 0 0 2 I I 
89 3 0 0 12 12 2 0 I 0 I 0 2 0 I 0 I I 6 I 1 5 3 4 
90 3 0 0 6 45 2 I 2 I I 0 2 1 I I 0 I 3 I 3 4.6 3 3 
91 2 I 2 6 12 0 I 2 2 I 0 1 I 0 0 I I 5 I I 12 3 3 
92 3 0 0 2.8 3.5 I 1 2 I 2 0 0 I 0 0 0 I I 0 4 I 2 
93 3 0 0 1.35 2.4 I 0 I I 1 0 0 0 I I 0 0 0 I I 2 0 I 
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GLOSSARY OF TERMS 
Dysplasia: 	 Abnormal development of tissue. 
Dystrophy: 	 Disorder of tissue due to impaired nourishment of the affected part. 
Figo Stage: 	 Classification used to define the extent of spread of certain types of 
cancer. 
Histologic Grade: Classification to differentiate tumors. 
Keratin: 	 Fibrous protein that forms horny tissues. 
LVS: 	 Lymph Vascular Space Invasion. 
Mitosis: 	 Mitotic index 
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